
Data-Driven Precision Medical Service Market Report 2026
Global Outlook – By Type (Cloud-Based, On-Premises), By Technology (Artificial Intelligence And Machine Learning, Big Data Analytics, Genomics And Sequencing, Cloud Computing, Blockchain, Digital Twin Technology, Wearables And Internet Of Things), By Application (Hospital, Clinic, Other Applications) - Market Size, Trends, And Global Forecast 2026-2035
Data-Driven Precision Medical Service Market Overview
• Data-Driven Precision Medical Service market size has reached to $165.24 billion in 2025 • Expected to grow to $407.17 billion in 2030 at a compound annual growth rate (CAGR) of 19.7% • Growth Driver: Surge In Adoption Of Cloud-Based Solutions Fueling The Growth Of The Market Due To Scalability And Real-time Data Access • Market Trend: Accelerating Personalized Treatment Strategies With AI-powered Insights • North America was the largest region in 2025.What Is Covered Under Data-Driven Precision Medical Service Market?
Data-driven precision medical service refers to healthcare solutions that leverage patient-specific data, advanced analytics, and computational tools to deliver highly personalized diagnosis, treatment, and preventive care. It integrates genomic, clinical, and lifestyle information to optimize medical decisions and improve outcomes. The main types of data-driven precision medical services are cloud-based and on-premises. Cloud-based solutions are hosted on secure platforms, allowing scalable storage, real-time access, and advanced analytics of patient health data. These services leverage technologies such as artificial intelligence and machine learning, big data analytics, genomics and sequencing, cloud computing, blockchain, digital twin technology, wearables, and the Internet of Things (IoT). They are applied across various healthcare settings, including hospitals, clinics, and other medical facilities, enabling more personalized, efficient, and data-driven patient care.
What Is The Data-Driven Precision Medical Service Market Size and Share 2026?
The data-driven precision medical service market size has grown rapidly in recent years. It will grow from $165.24 billion in 2025 to $198.28 billion in 2026 at a compound annual growth rate (CAGR) of 20.0%. The growth in the historic period can be attributed to increasing digitization of healthcare records, growth in genomic data availability, rising adoption of analytics-driven care models, expansion of healthcare IT infrastructure, increasing collaboration between tech and healthcare providers.What Is The Data-Driven Precision Medical Service Market Growth Forecast?
The data-driven precision medical service market size is expected to see rapid growth in the next few years. It will grow to $407.17 billion in 2030 at a compound annual growth rate (CAGR) of 19.7%. The growth in the forecast period can be attributed to increasing investments in ai-powered healthcare platforms, rising demand for personalized treatment pathways, expansion of real-time clinical decision support, growing adoption of wearable health data integration, increasing focus on preventive precision medicine. Major trends in the forecast period include increasing adoption of AI-driven clinical analytics, growing integration of multi-omics data platforms, expansion of cloud-based precision medicine services, rising use of predictive healthcare models, enhanced focus on outcome-based care.Global Data-Driven Precision Medical Service Market Segmentation
1) By Type: Cloud-Based, On-Premises 2) By Technology: Artificial Intelligence And Machine Learning, Big Data Analytics, Genomics And Sequencing, Cloud Computing, Blockchain, Digital Twin Technology, Wearables And Internet Of Things 3) By Application: Hospital, Clinic, Other Applications Subsegments: 1) By Cloud-Based: Public Cloud Deployment, Private Cloud Deployment, Hybrid Cloud Deployment 2) By On Premises: Dedicated Server Infrastructure, Enterprise Data Center Deployment, Localized Computing EnvironmentWhat Is The Driver Of The Data-Driven Precision Medical Service Market?
The growing adoption of cloud-based solutions is expected to propel the growth of the data-driven precision medical service market going forward. Cloud-based solutions refer to software, platforms, or infrastructure delivered over the internet, enabling on-demand access, storage, and computing without local installation. The adoption of cloud-based solutions is driven by their scalability, as they allow organizations to quickly adjust computing resources based on demand without heavy upfront infrastructure investment. The scalability of cloud-based solutions allows healthcare organizations to rapidly adjust resources based on demand, supporting real-time patient data analysis, predictive modeling, and personalized care. For instance, according to the Ace Cloud (Ace Cloud Hosting), a US-based cloud computing solution specialized for healthcare and HealthTech applications, the healthcare sector is rapidly embracing cloud technology, with 95% of organizations using it for patient data management. In 2025, cloud adoption in healthcare surged 41% year-over-year, marking the highest growth among all industry sectors. Therefore, the growing adoption of cloud-based solutions is expected to drive the growth of the data-driven precision medical service industry.Key Players In The Global Data-Driven Precision Medical Service Market
Major companies operating in the data-driven precision medical service market are Samsung Electronics Co. Ltd., Roche Holding AG, Novartis AG, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., BioNTech SE, QIAGEN N.V., Natera Inc., Precision Medicine Group Inc., Guardant Health Inc., Tempus Labs Inc., Flatiron Health Inc., Certara L.P., Verily Life Sciences LLC, GenomOncology Inc., SOPHiA GENETICS SA, Recursion Pharmaceuticals Inc., DNAnexus Inc., Biomea Fusion Inc.Global Data-Driven Precision Medical Service Market Trends and Insights
Major companies in the data-driven precision medical service market are increasingly focusing on advanced innovations, such as deep learning for multi-omics discovery, to accelerate biomarker identification, optimize personalized treatment strategies, and enhance clinical decision-making across oncology and other therapeutic areas. Deep learning for multi-omics discovery involves leveraging AI algorithms to analyze complex genomic, epigenomic, transcriptomic, and proteomic data, enabling the identification of novel biomarkers and therapeutic targets. For instance, in January 2023, Guardant Health, a US-based biotechnology company, launched Guardant Galaxy, a comprehensive suite of advanced analytical tools. Developed through both internal research and external collaborations, this platform aims to improve the accuracy and clinical utility of Guardant Health’s existing cancer testing portfolio. By integrating cutting-edge analytics, Guardant Galaxy supports more precise patient diagnostics and personalized treatment planning, while also accelerating the discovery of new biomarkers and therapeutic targets, fueling the next generation of drug development.What Are Latest Mergers And Acquisitions In The Data-Driven Precision Medical Service Market?
In July 2025, Samsung Electronics, a South Korea–based provider of consumer electronics, acquired Xealth for an undisclosed amount. With this acquisition, Samsung aims to enhance its connected care platform by integrating its wearable-generated consumer health data with Xealth’s digital health orchestration, thereby bridging wellness tools and clinical decision workflows within electronic health records. Xealth is a US–based provider of a data-driven platform that enables health systems to deliver precision medical services by integrating various digital health tools.Regional Outlook
North America was the largest region in the data-driven precision medical service market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Data-Driven Precision Medical Service Market?
The data-driven precision medical service market includes revenues earned by entities through genomic-based services, predictive analytics services, and clinical decision support services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Data-Driven Precision Medical Service Market Report 2026?
The data-driven precision medical service market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the data-driven precision medical service industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Data-Driven Precision Medical Service Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $198.28 billion |
| Revenue Forecast In 2035 | $407.17 billion |
| Growth Rate | CAGR of 20.0% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type, Technology, Application |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Samsung Electronics Co. Ltd., Roche Holding AG, Novartis AG, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., BioNTech SE, QIAGEN N.V., Natera Inc., Precision Medicine Group Inc., Guardant Health Inc., Tempus Labs Inc., Flatiron Health Inc., Certara L.P., Verily Life Sciences LLC, GenomOncology Inc., SOPHiA GENETICS SA, Recursion Pharmaceuticals Inc., DNAnexus Inc., Biomea Fusion Inc. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
